Parasite Transmission: A two-stage solution
Many life-threatening pathogens – such as parasites, bacteria and viruses – use insects to pass from one mammal to the next (Wilson et al., 2020). For example, tsetse flies transmit Trypanosoma brucei, the parasite that causes the deadly disease known as African sleeping sickness. When the tsetse fly bites and sucks up the blood of an infected animal, it takes up the parasite which then undergoes various changes before getting injected into a new mammalian host when the insect feeds again.
T. brucei has a complex lifecycle involving multiple stages that allow the parasite to adapt to life within each host, and prepare for transmission into the next (Koch, 1909; Vickerman, 1985). In the mammalian host, T. brucei parasites initially travel to the bloodstream where they develop into a slender form that divides multiples times and disseminates to other tissues and organs (Krüger et al., 2018). As the population of parasites in the blood increases, density signals as well as other stimuli cause some of them to transition into a new, non-dividing form known as stumpy (Rojas et al., 2019; Vassella et al., 1997; Quintana et al., 2021; Zimmermann et al., 2017).
Both forms of the parasite are consumed when the tsetse fly takes blood from the mammalian host. The ingested T. brucei parasites then enter the midgut where they continue their lifecycle as they migrate back through the proventriculus (a valve-like organ that guards the entrance to the midgut) to then reach the salivary glands (Figure 1A).
Previous research has shown that parasites in the stumpy form are resistant to the digestive effects of proteases in the midgut and are better equipped to use the energy sources available in the fly (Silvester et al., 2017). Furthermore, parasites usually enter the non-dividing stumpy stage before differentiating into the next phase of the lifecycle, the procyclic form. These findings have led to the belief that only parasites in the stumpy form are able to infect the tsetse fly and progress through the lifecycle, establishing a scientific dogma about parasite transmission.
However, infected mammals typically only have small amounts of parasites in their blood, as T. brucei will have spread to other tissues and organs. Therefore, the chances of a tsetse fly ingesting parasites during a blood meal is very low, particularly those in the stumpy form, which can only survive in the blood for three days before dying (Turner et al., 1995). Now, in eLife, Markus Engstler and colleagues from the University of Würzburg – including Sarah Schuster, Jaime Lisack and Ines Subota as joint first authors – report new findings that help explain how African sleeping sickness is able to persist when transmission appears so unlikely (Schuster et al., 2021).
The team were originally interested in comparing the transmission efficiency of stumpy forms that had been generated by different stimuli, using the slender stage as a negative control for their experiments. The insects were fed with blood containing parasites in the slender or stumpy form which can be distinguished by a fluorescent marker that is only expressed in the stumpy stage. Unexpectedly, Schuster et al. found that parasites in the slender form were able to survive the harsh conditions of the insect midgut and went on to infect the proventriculus and the salivary glands.
Next, Schuster et al. set out to determine how many parasites of each form are required for infection by limiting the number of T. brucei parasites present in the blood fed to the flies. The experiments showed that only a single slender or stumpy form is needed for the parasite to be sufficiently transmitted between mammals and flies. These findings not only challenge the predominant theory that T. brucei needs to be in the stumpy form to successfully infect tsetse flies, but they also show how transmission can take place when the concentration of parasites in the blood is incredibly low.
Finally, Schuster et al. found that when slender forms reach the tsetse midgut, they can directly differentiate into the procyclic form without having to pass through the stumpy stage (Figure 1B). This result contradicts the textbook lifecycle of T. brucei, in which slender forms have to transition to the cell-cycle arrested stumpy stage before entering the next phase of the lifecycle. Thus, this work raises important questions about the role of the stumpy form in parasite biology.
These findings help solve the long-standing paradox of how mammals with low numbers of T. brucei parasites in their blood can still infect tsetse flies. In the future, it will be necessary to test if this behavior is also present in other subspecies of T. brucei, especially those which cause disease in humans, such as T. brucei gambiense and T. brucei rhodesiense. Finding more genes that are specifically activated in slender, stumpy and other forms of the parasite would also help researchers distinguish between the different stages of the lifecycle. These additional molecular markers would make it easier to follow the temporal changes that occur in vivo when parasites colonize the tsetse fly.
References
-
BookBericht Über Die Tätigkeit Der Zur Erforschung Der Schlafkrankheit Im JahreSpringer.
-
Beyond blood: African trypanosomes on the moveTrends in Parasitology 34:1056–1067.https://doi.org/10.1016/j.pt.2018.08.002
-
Evolving differentiation in African trypanosomesTrends in Parasitology 37:296–303.https://doi.org/10.1016/j.pt.2020.11.003
-
Developmental cycles and biology of pathogenic trypanosomesBritish Medical Bulletin 41:105–114.https://doi.org/10.1093/oxfordjournals.bmb.a072036
-
The importance of vector control for the control and elimination of vector-borne diseasesPLOS Neglected Tropical Diseases 14:e0007831.https://doi.org/10.1371/journal.pntd.0007831
Article and author information
Author details
Publication history
Copyright
© 2021, Guegan and Figueiredo
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 744
- views
-
- 38
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Microbiology and Infectious Disease
The telomerase RNA component (Terc) constitutes a non-coding RNA critical for telomerase function, commonly associated with aging and pivotal in immunomodulation during inflammation. Our study unveils heightened susceptibility to pneumonia caused by Staphylococcus aureus (S. aureus) in Terc knockout (Tercko/ko) mice compared to both young and old infected counterparts. The exacerbated infection in Tercko/ko mice correlates with heightened inflammation, manifested by elevated interleukin-1β (IL-1β) levels and activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome within the lung. Employing mRNA sequencing methods alongside in vitro analysis of alveolar macrophages (AMs) and T cells, our study elucidates a compelling correlation between Tercko/ko, inflammation, and impaired T cell functionality. Terc deletion results in compromised T cell function, characterized by dysregulation of the T cell receptor and absence of CD247, potentially compromising the host’s capacity to mount an effective immune response against S. aureus. This investigation provides insights into the intricate mechanisms governing increased vulnerability to severe pneumonia in the context of Terc deficiency, which might also contribute to aging-related pathologies, while also highlighting the influence of Terc on T cell function.
-
- Microbiology and Infectious Disease
Phage-derived peptidoglycan hydrolases (i.e. lysins) are considered promising alternatives to conventional antibiotics due to their direct peptidoglycan degradation activity and low risk of resistance development. The discovery of these enzymes is often hampered by the limited availability of phage genomes. Herein, we report a new strategy to mine active peptidoglycan hydrolases from bacterial proteomes by lysin-derived antimicrobial peptide-primed screening. As a proof-of-concept, five peptidoglycan hydrolases from the Acinetobacter baumannii proteome (PHAb7-PHAb11) were identified using PlyF307 lysin-derived peptide as a template. Among them, PHAb10 and PHAb11 showed potent bactericidal activity against multiple pathogens even after treatment at 100°C for 1 hr, while the other three were thermosensitive. We solved the crystal structures of PHAb8, PHAb10, and PHAb11 and unveiled that hyper-thermostable PHAb10 underwent a unique folding-refolding thermodynamic scheme mediated by a dimer-monomer transition, while thermosensitive PHAb8 formed a monomer. Two mouse models of bacterial infection further demonstrated the safety and efficacy of PHAb10. In conclusion, our antimicrobial peptide-primed strategy provides new clues for the discovery of promising antimicrobial drugs.